Complete Genomics Inc's ROA from the third quarter of 2012 to the third quarter of 2011 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Complete Genomics Inc's ROA in the third quarter of 2012?
Complete Genomics Inc recorded a cumulative net loss of $-57 million during 12 months ending in the third quarter of 2012, resulting in a negative return on assets (ROA) of -54.42%.

However, within the Healthcare sector Complete Genomics Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the second quarter of 2012 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2012) III. Quarter	(Jun 30 2012) II. Quarter	(Mar 31 2012) I. Quarter	(Dec 31 2011) IV. Quarter	(Sep 30 2011) III. Quarter
Y / Y Total Assets Change	-44.71 %	-43.14 %	10.2 %	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-57	-61	-58	-50	-70
Return On Assets (TTM)	-54.42 %	-50.07 %	-41.52 %	-36.63 %	-67.75 %
GNOM's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	81	95	113	130	146
Seq. Total Assets Change	-15.23 %	-15.97 %	-13 %	-10.79 %	-12.81 %
Seq. Net Income Change	-	-	-	-	-

GNOM's 5 Years Annual ROA >> Back to GNOM Management Effectiveness >> Compare GNOM ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Complete Genomics Inc's Assets	$ 81 million	GNOM's Balance sheet
Complete Genomics Inc's Income	$ -18 million	Quarterly GNOM's Income Statement
GNOM's Income by Division		See GNOM's Income by Division

Annual Return On Assets	(Dec 31 2011) FY 2011	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	130	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-72	0	0	0	0
Annual Return On Assets	-55.57 %	-	-	-	-

GNOM's 5 Years Annual ROA >> Back to GNOM Management Effectiveness >> Compare GNOM ROA to its Competitors

More Return On Assets Ratios
GNOM's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
GNOM's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for GNOM's Competitors
Subscribers only: Roa for Complete Genomics Inc's Suppliers
Subscribers only: Return On Assets for GNOM's Customers

You may also want to know
GNOM's Roi	GNOM's Inventory Turnover Ratio	GNOM's Growth Rates	GNOM's Dividend Comparisons
	GNOM's Profitability Ratios	GNOM's Asset Turnover Ratio	GNOM's Dividend Growth
GNOM's Roe	GNOM's Valuation Ratios	GNOM's Financial Strength Ratios	GNOM's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2012, within Healthcare Sector

ROA

Date modified: 2026-09-08T15:07:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.